Federation des caisses Desjardins du Quebec’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.4K Sell
1,347
-68
-5% -$3.24K ﹤0.01% 1815
2026
Q1
$61.8K Hold
1,415
– – ﹤0.01% 1803
2025
Q4
$64.3K Hold
1,415
– – ﹤0.01% 1757
2025
Q3
$54.8K Sell
1,415
-1
-0.1% -$36 ﹤0.01% 1786
2025
Q2
$47.7K Hold
1,416
– – ﹤0.01% 1570
2025
Q1
$45K Buy
1,416
+1,062
+300% +$40.3K ﹤0.01% 1502
2024
Q4
$13.7K Hold
354
– – ﹤0.01% 1771
2024
Q3
$15.9K Hold
354
– – ﹤0.01% 1732
2024
Q2
$14.8K Hold
354
– – ﹤0.01% 1698
2024
Q1
$16.1K Hold
354
– – ﹤0.01% 1695
2023
Q4
$16.4K Hold
354
– – ﹤0.01% 1634
2023
Q3
$14.4K Hold
354
– – ﹤0.01% 1660
2023
Q2
$17.1K Sell
354
-25
-7% -$1.25K ﹤0.01% 1619
2023
Q1
$18.7K Hold
379
– – ﹤0.01% 1588
2022
Q4
$19.2K Hold
379
– – ﹤0.01% 1691
2022
Q3
$19K Hold
379
– – ﹤0.01% 1749
2022
Q2
$18.5K Buy
379
+87
+30% +$4.41K ﹤0.01% 1783
2022
Q1
$17.5K Buy
292
+4
+1% +$252 ﹤0.01% 1867
2021
Q4
$22.8K Buy
288
+25
+10% +$2.1K ﹤0.01% 1794
2021
Q3
$23.2K Hold
263
– – ﹤0.01% 1808
2021
Q2
$26.1K Buy
263
+182
+225% +$16.1K ﹤0.01% 1787
2021
Q1
$7.31K Buy
+81
New +$8K ﹤0.01% 2080

Other funds holding GNOM

Federation des caisses Desjardins du Quebec's GNOM Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 4.8% in Q2 2026, selling an estimated $3.24K and leaving 1,347 shares worth $76.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1815.

Federation des caisses Desjardins du Quebec first reported a position in GNOM in Q1 2021 and has held it in 22 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 1,347 shares of Global X Genomics & Biotechnology ETF worth $76.4K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec sold 68 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $3.24K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1815 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.